Digestive System
Daclahepex
Daclatasvir 60 mg - 28 Film-coated tablets
Generic Name
Daclatasvir
Composition:
Active substance: Daclatasvir Dihydrochloride 66 mg Eq. to Daclatasvir 60 mg.
Pharmaceutical form:
Film coated tablets.
Physical characters:
green. round. biconvex, plain from sides, film coated tablets.
green. round. biconvex, plain from sides, film coated tablets.
Therapeutic Indications:
Daclahepex is indicated in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults.
Approved by Egyptian Drug Authority: SF0295OA6172/052026 . Invalidation date: 19/05/2027
Kindly report any violated online promotional, educational and awareness material not having this message to The General administration for Regulation of Marketing & Advertising Materials at www.edaegypt.gov.eg”